Materials engineered for use with specific printers and qualified for verifiable repeatability and accuracy help ensure long-term mechanical properties ranging from heat resistance to biocompatibility.
If everyone were to stand in a single-file line, patients on the U.S. organ transplant waiting list would form a line over 70 miles long.
Using 3D printing, or additive manufacturing (AM), in health care is on the rise, with the market expected to be worth nearly $26 billion by 2022. This growth goes well beyond just prototyping, as AM is already used throughout the industry to solve problems and improve care.
Design engineer Glen Dobbs has talent, curiosity, resourcefulness, and perhaps the most important attribute of all—a big heart. Dobbs is the President and CEO of LoganTech, a manufacturer of several lines of communications devices for nonverbal and visually impaired individuals.
DanaMedInc.’s Pathfinder ACL Guide is a biocompatible surgical device enabling surgeons to better reconstruct partially or fully torn anterior cruciate ligaments (ACL) and reduce the risk of re-tearing.
Formlabs was founded by MIT researchers in 2011, when high-quality 3D printing was inaccessible for most. We’ve now shipped over 50,000 machines while cementing our mission to “expand access to digital fabrication, so anyone can make anything.”
AM is used in everything from aerospace and automotive to consumer products. But some of the earliest and most significant applications are in healthcare. To this end, the theme of this month’s Manufacturing Engineering is medical machining.
The third in its series of Industry 4.0 playbooks, “Shaping Tomorrow: Mastering Additive Manufacturing” focuses on the impact of AM on traditional design processes.
Ready for more disruption in a rapidly changing manufacturing industry? Why artificial intelligence and machine learning are the next big thing in 3D printing.
Optimizing performance by teaming different materials.